News

Progen Pharmaceuticals said that the new contract further validates PharmaSynth as an important Australian based contract manufacturer with expertise in recombinant proteins, bacterial and viral vaccines, whole cell

The anti-malarial drug, Artequick, is a four-pill treatment, currently being marketed in 11 countries where the incident rate of malaria is high. As per the terms of the

Biogen Idec posted a net income of $219.99m for the first quarter 2010, or $0.80 per diluted share, compared to $246.57m, or $0.84 per diluted share, for the

MarquipWardUnited said that the new Apollo TSKM would help Thoro Packaging save outsourcing costs from heavier caliper sheets and reduce waste with the help of improved triple station

Eli Lilly has posted a net income of $1.25bn, or $1.13 per diluted share, a decrease of 5%, compared to $1.31bn, or $1.20 per diluted share, for the

NanoBio and the University of Michigan’s, Michigan Nanotechnology Institute for Medicine and Biological Sciences have received funding through a Phase 1 Technology Transfer (STTR) award by the National

The PCR system offers a number of performance and usability enhancements that are expected to advance the understanding of molecular biology in the pharmaceutical discovery and clinical research

In addition to providing technology systems that help all pharmaceutical companies print Standardized Numerical Identification (SNI) codes on all secondary packaging, Covectra offers unit-dose identification technology that provides

Bioniche’s research activities are focused mainly on small-scale, bench-top experiments. In order to scale-up the associated processes, a facility is required that houses pilot-scale fermentation equipment and downstream